Summary: We introduce a fast, sensitive, label-free method for the detection of Betaxolol
hydrochloride (BH) based on fluorescent dye/graphene oxide (FD/GO) fluorescence sensor.
Table 1 Summary of drugs used to treat glaucoma Drug, strength and Trade name and Side effects and bottle size preservatives contraindications Betaxolol Betaxolol
Beta blockers hydrochloride Benzalkonium Transient discomfort 0.5% 5mL chloride (BC), 25%, Disodium edetate tearing 5%, stinging.
Ocular irritation was reported by 1 (1.35%) patient on timolol + bimatoprost, 1 (1.35%) on timolol + acetazolamide, 2 (2.70%) on betaxolol
, and 1 (1.35%) patient on bimatoprost had reported ocular stinging.
Cardiosseletivos Nao seletivos Drogas com atividade al antagonista adicional Acebutolol * Alprenolol * Bucindolol Atenolol Carteolol * Carvedilol Betaxolol
Nadolol Labetalol Bevantolol Oxprenolol * Bisoprolol Penbutolol * Celiprolol Pindolol * Esmolol Propranolol Metoprolol Sotalol Practolol * Timolol Quadro 4: Criterios usados na selecao e forma de obtencao dos dados.
(2,4,6) Mechanism Drug Class Preparations of Action Reduction Adrenergic Brimonidine of Aqueous agonists Apraclonidine Inflow [beta]-blockers Non-selective Timolol Levobunolol Carteolol Selective [beta]-blockers Betaxolol
Carbonic Systemic anhydrase Acetazolamide inhibitors Methazolamide Dichlorphenamide Topical Dorzolamide Brinzolamide Increase Cholinergics Pilocarpine in Aqueous Increase Carbachol Outflow trabecular outflow Prostaglandins Latanoprost (xalatan) and other lipid Travoprost (travatan) receptor agonists Increase Bimatoprost (lumigan) uveoscleral Unoprostone outflow Table 2: The Demographic Data of the Patients of POAG Selected for the Study Bimatoprost Timolol Maleate No.
Four of the five beta-adrenergic blockers have no human eye data: betaxolol
(Betoptic), carteolol (Ocupress), levobunolol (Betagan), and metipranolol, but there are two case reports for timolol (Betimol, Istalol, Timoptic, Timoptic-XE) showing no fetal harm in one newborn and growth restriction in the other.
However, Collignon and Collignon-Brach  described an extension of retinal vessel diameter after 12-24 months of betaxolol
therapy in comparison with placebo.
Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol
in the treatment of neuroleptic-induced akathisia.